Loading organizations...
Healios is a digital healthcare technology company that delivers online mental health and neurodevelopmental services. It provides therapeutic support and assessments for conditions including autism and ADHD, functioning as a digital partner to healthcare systems. The company leverages its proprietary platform to offer accessible and integrated care pathways, focusing on delivering specialist interventions remotely.
Founded in 2013 by Richard Andrews, Healios emerged from Andrews' observation of significant gaps in traditional mental healthcare provision. With a background in the sector, Andrews sought to address these systemic shortcomings by building a technology-driven solution. His founding insight was to create a scalable digital service that could overcome geographical barriers and reduce waiting times for crucial support.
The company primarily serves patients and families seeking support for mental health challenges and neurodiverse conditions, working closely with public healthcare providers such as the NHS. Healios' long-term vision centers on transforming access to mental healthcare, aiming to empower individuals and families by making essential services more accessible and effective through advanced digital platforms.
Healios has raised $31.9M across 4 funding rounds.
Healios has raised $31.9M in total across 4 funding rounds.
Healios has raised $31.9M across 4 funding rounds. Most recently, it raised $16.0M Series B in November 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 1, 2022 | $16M Series B | — | Albion VC, Autism Impact Fund, Connect Ventures, WGI Group, James Meekings, Noah Goodhart | Announced |
| May 1, 2021 | $10M Series A | Richard Bradford | Albion VC, Autism Impact Fund, Connect Ventures, WGI Group, James Meekings, Noah Goodhart | Announced |
| Jun 19, 2018 | $2.9M Venture Round | Albionvc, Spice Capital | — | Announced |
| Jun 1, 2018 | $3M Series U | — | Albion VC, Autism Impact Fund | Announced |
Healios (UK-based, healios.org.uk) is a digital healthcare company founded in 2013 that provides online mental health, autism, and ADHD services for children, young people, adults, and their families.[1][3][4] It builds the Panacea platform, a proprietary tool for remote assessments, video therapy sessions, appointment management, interactive tools, and family involvement, primarily serving the UK's healthcare sector through NHS partnerships and direct users.[1][3][4] The platform addresses critical gaps in accessible mental health support by enabling remote care, blending clinical expertise with technology to sustain healthier habits beyond sessions, with $28.59M raised (latest Series B in 2022) and reported revenue around $20.6M.[1][3]
This solves long waiting times and limited access to specialized care for neurodevelopmental conditions and mental illnesses, targeting ages 5+ with family-inclusive interventions.[1][4] Growth includes partnerships with the NHS, platform innovations like virtual supporter sessions, and expansion amid rising demand for digital mental health post-pandemic, though recent Mosaic Score declined -59 points.[1][3]
Healios emerged in 2013 in London, UK, after founders identified gaps in mental health support systems for children and young people, particularly the lack of accessible treatment and family involvement.[1][3] The company was driven by a mission to transform mental healthcare through technology, emphasizing support networks and remote delivery.[1] Early traction came from developing the Panacea platform and securing NHS partnerships, enabling scalable online services for autism, ADHD, and mental health.[1][4] Pivotal moments include raising $15.78M in Series B funding around 2022 and repositioning services amid evolving NHS needs, as highlighted in 2025 news on embracing mental health service changes.[1]
(Note: A separate Japanese biotech firm, Healios K.K., focuses on iPS cell therapies but is distinct from this UK digital health player.[2][5])
Healios rides the digital mental health wave, accelerated by post-pandemic demand for remote care and NHS pressures on child/young people services.[1] Timing aligns with UK policy shifts toward telehealth for neurodevelopmental conditions like autism/ADHD, where waiting lists exceed years, making scalable platforms essential.[1][4] Market forces favoring it include rising mental health awareness, government digital health investments, and family-involved care trends, positioning Healios to influence ecosystem-wide adoption of hybrid clinician-tech models.[1][3] It shapes the landscape by pioneering beyond-clinical interventions, inspiring competitors and informing NHS service evolution.[1]
Healios is poised to expand Panacea amid surging UK demand for child mental health tech, potentially deepening NHS integrations and international outreach.[1][4] Trends like AI-enhanced therapy tools and preventive family interventions will shape its path, boosting efficiency amid clinician shortages.[1][3] Its influence may grow as a benchmark for accessible digital care, evolving from startup to essential healthcare infrastructure—transforming gaps in support into "exceptional healthcare anytime, anywhere," as its mission promises.[3][4]
Healios has raised $31.9M in total across 4 funding rounds.
Healios's investors include Albion VC, Autism Impact Fund, Connect Ventures, WGI Group, James Meekings, Noah Goodhart, Richard Bradford, AlbionVC, Spice Capital.
